Where are the DIVAA™ angioreactors implanted?
FAQ from Trevigen
The angioreactors should be implanted on the dorsal lateral flanks.
These areas exhibit sufficient vasculature to support initiation of angiogenesis, and they are also strategically positioned to prevent removal by the host mouse. Other areas may be used for implantation; however, this is outside of the product specification. Please consult the scientific literature for more information.